本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.30
+0.639996.94%
盤後1.20-0.0954-7.34%19:59 EDT
成交量:1.42億
成交額:1.74億
市值:133.78萬
市盈率:-0.02
高:1.55
開:0.8800
低:0.8342
收:0.6601
52周最高:59.40
52周最低:0.6100
股本:102.91萬
流通股本:94.35萬
量比:1,179.56
換手率:15096.67%
股息:- -
股息率:- -
每股收益(TTM):-78.3088
每股收益(LYR):-67.2947
淨資產收益率:-64.72%
總資產收益率:-32.79%
市淨率:0.09
市盈率(LYR):-0.02

資料載入中...

2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC問詢函

Form CORRESP - Correspondence
2024/06/06

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/28

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/16

SEC問詢函

Form CORRESP - Correspondence
2023/12/16

SEC問詢函

Form CORRESP - Correspondence
2023/12/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/12/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses